PGR and breast carcinoma: In addition, neither tamoxifen nor trastuzumab which can effectively treat other subtypes of breast cancers is effective for TNBC due to the lack of estrogen receptors (ER), progesterone receptors (PR) and human epidermal growth factor receptor 2 (HER2) [1, 2].